LIVN - LivaNova ticks higher amid vague takeover speculation

LivaNova (LIVN ) rose 2.2% amid some vague takeover speculation following the company's Q4 results and some amendments for executive compensation in a potential acquisition.

LivaNova ( NASDAQ: LIVN ) disclosed on Wednesday in a filing that it's compensation committee amended some forms of award agreements for executives in connection with an acquisition of the company, Gordon Haskett's Don Bilson highlighted in a note on Thursday. He added thought that the tweaks that were made are often standard and part of a routine update.

The takeover speculation comes after the FT reported in March 2021 that private equity firm Permira bid for $3.7 billion , or $80/share, for LivaNova (LIVN.) There was also press speculation in February 2020 that a LivaNova potential sale to Medtronic ( MDT ) was pitched.

In March 2021 analysts said that a LivaNova ( LIVN ) takeout at $90/share would be attractive. LIVN hit a 52-week high of $88 in April of last year.

The Thursday uptick in the shares also comes after LivaNova ( LIVN ) stock fell 11% on Wednesday after Q4 results were released.

For further details see: